A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapy

Abstract Background The applicability and therapeutic efficacy of specific personalized immunotherapy for cancer patients is limited by the genetic diversity of the host or the tumor. Side-effects such as immune-related adverse events (IRAEs) derived from the administration of immunotherapy have als...

Descrición completa

Detalles Bibliográficos

Principais autores:	Chia-Hung Chen, Tzu-Han Weng, Hsiao-Hsuan Huang, Ling-Ya Huang, Kai-Yao Huang, Pin-Rong Chen, Kuang-Yu Yeh, Chi-Ting Huang, Yu-Tzu Chien, Po-Ya Chuang, Yu-Ling Lin, Nu-Man Tsai, Shih-Jen Liu, Yu-Cheng Su, Shun-Long Weng, Kuang-Wen Liao
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2023-01-01
Series:	Journal of Experimental & Clinical Cancer Research
Assuntos:	LPPC Immunotherapy Costimulatory molecules personalized cancer therapy Tumor heterogenicity
Acceso en liña:	https://doi.org/10.1186/s13046-023-02601-8
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!